Low-dose enoximone improves exercise capacity in chronic heart failure*
Brian D. Lowes, MDa,
Michael Higginbotham, MDa,
Lawrence Petrovich, MD, FACCa,
Marcus A. DeWood, MDa,
Mark A. Greenberg, MDa,
Peter S. Rahko, MDa,
G. William Dec, MD, FACCa,
Thierry H. LeJemtel, MDa,
Robert L. Roden, MSa,
Margo M. Schleman, MD, FACCa,
Alastair D. Robertson, PhDa,
Richard J. Gorczynski, PhDa,
Michael R. Bristow, MD, PhD, FACCa for the Enoximone Study Group
a Heart Failure Treatment Program, University of Colorado Health Sciences Center, Denver, Colorado, USA
View larger version (17K):
[in a new window]
|
Figure 2 Last Observation Carried-Forward Analysis.
|
|
|
